Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mark Blumenkranz
AddedMar 31, 2024
UpdatedMay 1, 2026
Mark Blumenkranz

Mark Blumenkranz

Board Member, One Medical

Mark Blumenkranz's Career

One Medical
One Medical

Austin, TX, US

Board Member· Board
KALA BIO
KALA BIO

Arlington, MA, US

Board Member· Board
Verana Health
Verana Health

San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mark Blumenkranz's Career

One Medical
One Medical
Public$532.1M3.7k2007Austin, TX, US
Board Member· Board

Leadership at One Medical

Tom X LeeTom X LeeBoard Member
Amir Dan RubinAmir Dan RubinBoard Member
Krishna YeshwantKrishna YeshwantBoard Member
Bruce DunlevieBruce DunlevieBoard Member
Andrew AdamsAndrew AdamsBoard Member
Mary Ann TocioMary Ann TocioBoard Member

Similar to One Medical

OnMedOnMedTampa, FL, USVirtual Careest. 2013OnMedTampa, FL, US · est. 2013

OnMed: Quality, affordable virtual healthcare through innovative technology.

Series A · $6.1M57
Carbon HealthCarbon HealthSan Francisco, CA, USHealthcare, Telemedicineest. 2015Carbon HealthSan Francisco, CA, US · est. 2015

Carbon Health: A US-based healthcare chain offering primary, urgent care, and telemedicine services.

Series D · $622.5M2.3k
DoximityDoximitySan Francisco, CA, USNetworking, Telehealthest. 2010DoximitySan Francisco, CA, US · est. 2010

Doximity, based in San Mateo, US, is a networking service providing curated medical news, telehealth tools, and collaboration for professionals.

Public · $81.8M977
Doctor On DemandDoctor On DemandSan Francisco, CA, USTelemedicineest. 2012Doctor On DemandSan Francisco, CA, US · est. 2012

Doctor On Demand: A leading video telemedicine firm, providing on-demand US-licensed healthcare via digital platforms.

Series D · $235.7M1.3k
KALA BIO
KALA BIO
Public342009Arlington, MA, US
Board Member· Board

Leadership at KALA BIO

Justin HanesJustin HanesBoard Member
Mark IwickiMark IwickiBoard Member
Andrew KovenAndrew KovenBoard Member

Similar to KALA BIO

KaloBios PharmaceuticalsKaloBios PharmaceuticalsSouth San Francisco, CA, USAntibodies, Pharmaceuticalsest. 2000KaloBios PharmaceuticalsSouth San Francisco, CA, US · est. 2000

KaloBios Pharmaceuticals: Advancing biopharmaceutical solutions for rare diseases and specific cancers.

Public · $56M11
Qlaris BioQlaris BioWellesley, MA, USTherapeuticsest. 2019Qlaris BioWellesley, MA, US · est. 2019

Therapeutics firm focusing on high-need areas in debilitating eye diseases.

Series A · $25M9
Cell Care TherapeuticsCell Care TherapeuticsMonrovia, CA, USBiopharmaceuticalsest. 2014Cell Care TherapeuticsMonrovia, CA, US · est. 2014

Cell Care Therapeutics: A California-based biopharmaceutical firm specializing in regenerative immunotherapies.

Seed · $5.3M7
Beilai BioBeilai BioIrvine, CA, USStem Cell Therapiesest. 2015Beilai BioIrvine, CA, US · est. 2015

Beilai Bio, a California-based biopharmaceutical firm, develops stem cell therapies for high-need diseases.

Series B · $300M30
Verana Health
Verana Health
Series E$288.8M2252008San Francisco, CA, US
Board Member· Board

Leadership at Verana Health

Steven SchwartzSteven SchwartzBoard Member
Brook ByersBrook ByersBoard Member
Miki KapoorMiki KapoorCo-Founder
Boris NikolicBoris NikolicBoard Member
Jeffrey LowJeffrey LowBoard Member
David ParkeDavid ParkeBoard Member

Mark Blumenkranz's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Mark Blumenkranz

Mitchell BluttMitchell BluttBoard Member · Consonance CapitalZeke EmanuelZeke EmanuelAmerican physicianCharles SchleienCharles SchleienBoard Member · Northwell HealthSteven FlanaganSteven FlanaganBoard Member · NYU Grossman School of MedicineLyle BerkowitzLyle BerkowitzCo-Founder · 2Flo VenturesDavid AgusDavid AgusBoard Member · Thrive Global